{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_5336", "batch_size": 260, "batch_pos": 11, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The language used is neutral.", "method": "llm_batch", "batch_id": "batch_2_14568", "batch_size": 260, "batch_pos": 248, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses ability to manufacture, lacking a moderate verb paired with scale/impact.", "method": "llm_batch", "batch_id": "batch_3_4428", "batch_size": 260, "batch_pos": 191, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_13776", "batch_size": 260, "batch_pos": 184, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment does not contain explicit calming language or intensified low-risk evaluation.", "method": "llm_batch", "batch_id": "batch_5_11744", "batch_size": 260, "batch_pos": 181, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_17040", "batch_size": 260, "batch_pos": 153, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment contains 'too early to tell' which is a negation of ability to know, not a bare negation about risk/fact/capability.", "method": "llm_batch", "batch_id": "batch_7_1604", "batch_size": 260, "batch_pos": 147, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes uncertainty about manufacturing capability ('too early to tell how many doses Moderna will be able to manufacture').", "method": "llm_batch", "batch_id": "batch_8_6676", "batch_size": 260, "batch_pos": 25, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
